1.
Mạnh PD, Toàn PK, Huy TL. 82. Gefitinib rechallenge After Osimertinib-Induced Interstitial Lung Disease: A Case Report and Literature Review. TCNCYH [Internet]. 2025Oct.31 [cited 2026Nov.7];195(10):795-800. Available from: https://tapchinghiencuuyhoc.vn/index.php/tcncyh/article/view/3929